Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOTwith invasive peritoneal implants, which have aworse prognosis.We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT. Copyright © 2010 by IGCS and ESGO.

Giorgini, M., Marchetti, C., Di Donato, V., Tesei, J., Manci, N., Panici, P. B., Limits of 18F-Fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor, <<INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER>>, n/a; 20 (5): 694-697. [doi:10.1111/IGC.0b013e3181da2912] [http://hdl.handle.net/10807/205144]

Limits of 18F-Fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor

Marchetti, Claudia;
2010

Abstract

Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOTwith invasive peritoneal implants, which have aworse prognosis.We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT. Copyright © 2010 by IGCS and ESGO.
2010
AREA06 - SCIENZE MEDICHE
Pubblicazione su rivista con Impact Factor
Inglese
Articolo in rivista
Italiano
Borderline ovarian tumors
Recurrence
Total-body FDG-PET/CT
Settore MED/40 - GINECOLOGIA E OSTETRICIA
Settore MED/06 - ONCOLOGIA MEDICA
20
5
n/a
694
697
4
info:eu-repo/semantics/article
Giorgini, M., Marchetti, C., Di Donato, V., Tesei, J., Manci, N., Panici, P. B., Limits of 18F-Fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor, <<INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER>>, n/a; 20 (5): 694-697. [doi:10.1111/IGC.0b013e3181da2912] [http://hdl.handle.net/10807/205144]
none
262
Giorgini, M.; Marchetti, Claudia; Di Donato, V.; Tesei, J.; Manci, N.; Panici, P. B.
6
art_per_29
03. Contributo in rivista::Articolo in rivista, Nota a sentenza
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/205144
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact